罗建方,黄文晖,刘媛,李光,周颖玲,陈纪言,王慧勇

• 1:广东省心血管病研究所心内科
• 2:广东省人民医院广东省医学科学院
• 3:广州医学院第一附属医院心内科

摘要(Abstract)：

目的探讨经桡动脉途径行肾动脉狭窄介入治疗的安全性和有效性。方法自2010年10月至2011年2月,入选6例经桡动脉途径行肾动脉介入治疗的患者,桡动脉穿刺使用6Fr桡动脉鞘系统(Terum o,Japan),止血使用桡动脉止血带(Terumo,Japan),选择性肾动脉造影使用5FrMPA120cm造影管(COOK,USA),肾动脉支架术使用PCI(percutaneous coronary intervention,PCI)导丝、6FrMPA1 125cm指引导管(Cordis,USA)及肾动脉支架系统。结果肾动脉造影示:4例患者单肾动脉狭窄,2例患者双肾动脉狭窄。6例患者均经桡动脉途径行肾动脉介入治疗成功,无中转股动脉途径,技术成功率达100%。穿刺口恢复良好,无穿刺部位血肿、假性动脉瘤等发生。介入治疗时间(35±4.6)m in,造影剂(典必乐)用量(82.5±7.7)m l,止血时间(4.1±1.1)m in。结论经桡动脉途径行肾动脉狭窄介入治疗技术可行、创伤小、恢复快、并发症少,可能成为肾动脉狭窄介入治疗的另一途径。

关键词(KeyWords)： 肾动脉梗阻;桡动脉;血管成形术

Abstract:

Keywords:

基金项目(Foundation): 广东省科技计划项目(2009B030801267)

作者(Author): 罗建方,黄文晖,刘媛,李光,周颖玲,陈纪言,王慧勇

参考文献(References)：

• [1]Wozniak WT.Origin of the renal arteries from the sides of aorta.Folia Morphol(Warsz),2000,58:259-261.
• [2]Trani C,Tommasino A,Burzotta F,et al.Transradial renalstenting:why and how.Catheterizat Cardiovasc Interv,2009,74:951-956.
• [3]刘媛,罗建方,黄文晖,等.老年腹主动脉瘤患者冠状动脉造影的临床意义.中华心血管病学杂志,2011,39:53-56.
• [4]van de Ven PJ,Kaatee R,Beutler JJ,et al.Arterial stenting andballoon angioplasty in ostial atherosclerotic renovascular disease:A randomised trial.Lancet,1999,353:282-286.
• [5]van Jaarsveld BC,Krijnen P,Pieterman H,et al.The effect ofballoon angioplasty on hypertension in aterosclerotic renal-arterystenosis.N Engl J Med,2000,342:1007-1014.
• [6]Zeller T,Frank U,Müller C,et al.Predictors of improved renalfunction after percutaneous stent-supported angioplasty of severeatherosclerotic ostial renal artery stenosis.Circulation,2003,108:2244-2249.
• [7]Mistry S,Ives N,Harding J,et al.Angioplasty and STent forRenal Artery Lesions(ASTRAL trail):rationale,methods andresults so far.J Hum Hypertens,2007,21:511-515.
• [8]Jolly SS,Amlani S,Hamon M,et al.Radial versus femoralaccess for coronary angiography or intervention and the impact onmajor bleeding and ischemic events:A systematic review andmeta-analysis of randomized trials.Am Heart J,2009,157:132-140.
• [9]Cooper CJ,Haller ST,Colyer W,et al.Embolic protection andplatelet inhibition during renal artery stenting.Circulation,2008,117:2752-2760.
• [10]颜红兵,王嘉莉,焦媛,等.美国成人肾动脉狭窄诊断和介入治疗指南解读.中国介入心脏病学杂志,2003,11:326-327.
• [11]Campeau L.Percutaneous radial artery approach for coronaryangiography.Cathet Cardiovasc Diagn,1989,16:3-7.
• [12]Kiemeneij F,Laarman GJ.Percutaneous transradial arteryapproach for coronary Palmaz-Schatz stent implantation.AmHeart J,1994,128:167-174.
• [13]唐忠仁,李福玉,王英,等.经桡动脉与经股动脉途径行经皮冠状动脉介入治疗急性心肌梗死的对比研究.中国现代医药杂志,2010,12:40-42.
• [14]Agostoni P,Biondi-Zoccai GG,de Benedictis ML,et al.Radialversus femoral approach for percutaneous coronary diagnostic andinterventional procedures;systematic overview and meta-analysisof randomized trials.J Am Coll Cardiol,2004,44:349-356.
• [15]Kessel DO,Robertson I,Taylor EJ,et al.Renal stenting fromthe radial artery:a novel approach.Cardiovasc Intervent Radiol,2003,26:146-149.
• [16]Braunlich S,Ludwig J,Scheinert D,et al.Transradial renalartery angioplasty and stenting.J Invasive Cardiol,2002,14:147-149.
• [17]Scheinert D,Braunlich S,Nonnast-Daniel B.Transradialapproach for renal artery stenting.Catheter Cardiovasc Interv,2001,54:442-447.
• [18]Plouin PF,Chatellier G,DarnéB,et al.Blood pressure outcomeof angioplasty in atherosclerotic renal artery stenosis:Arandomized trial.Essai Multicentrique Medicaments vsAngioplastie(EMMA)Study Group.Hypertension,1998,31:823-829.